Phibro Animal Health Corp (PAHC) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2026, Phibro Animal Health reported revenue of $1.52B, up 17.1% from $1.30B the year before. Net income was $99.7M (a 6.6% net margin), or $2.43 per diluted share. Gross margin was 33.8% and operating margin was 12.8%. Operating activities generated $69.0M of cash, leaving $9.9M of free cash flow. At fiscal year end, Phibro Animal Health held $1.50B in total assets against $1.12B in total liabilities, including $61.4M of cash and equivalents.
Open the full interactive Phibro Animal Health financials → Quarterly statements, key ratios, valuation history and price charts.
Phibro Animal Health Key Stats
| Share Price | $36.81 |
|---|---|
| Market Cap | $1.51B |
| P/E Ratio | 15.1 |
| Revenue YoY Growth | +17.1% |
| 52-Week Range | $28.31 – $59.14 |
| Shares Outstanding | 40.5 million (basic, 2026 Q4) |
Phibro Animal Health Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $833.4M | $942.3M | $977.9M | $1.02B | $1.30B | $1.52B |
| Cost of Goods Sold | $562.0M | $656.9M | $679.7M | $704.6M | $896.3M | $1.01B |
| Gross Profit | $271.4M | $285.4M | $298.2M | $313.1M | $399.9M | $512.5M |
| Operating Income | $74.9M | $79.0M | $71.8M | $53.3M | $110.5M | $194.4M |
| Pre-Tax Income | $66.5M | $72.3M | $54.1M | $10.9M | $68.0M | $137.3M |
| Income Tax | $12.1M | $23.2M | $21.5M | $8.5M | $19.7M | $37.6M |
| Net Income | $54.4M | $49.2M | $32.6M | $2.4M | $48.3M | $99.7M |
| Diluted EPS | $1.34 | $1.21 | $0.81 | $0.06 | $1.19 | $2.43 |
Phibro Animal Health Quarterly Results
| 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | |
|---|---|---|---|---|
| Revenue | $363.9M | $373.9M | $383.5M | $396.7M |
| Net Income | $26.5M | $27.5M | $24.0M | $21.7M |
| Diluted EPS | $0.65 | $0.67 | $0.59 | $0.53 |
Phibro Animal Health Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $50.2M | $74.2M | $41.3M | $70.6M | $68.0M | $61.4M |
| Current Assets | $498.9M | $566.2M | $585.7M | $601.0M | $810.6M | $935.5M |
| Total Assets | $841.3M | $931.7M | $971.4M | $982.2M | $1.36B | $1.50B |
| Current Liabilities | $164.1M | $190.8M | $176.0M | $204.1M | $293.5M | $316.5M |
| Total Long-Term Debt | $306.5M | $432.9M | $333.8M | $312.1M | $718.7M | $732.8M |
| Total Liabilities | $602.8M | $669.3M | $688.9M | $725.5M | $1.08B | $1.12B |
| Shareholders' Equity | $238.5M | $262.4M | $282.5M | $256.6M | $285.7M | $385.5M |
Phibro Animal Health Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $48.3M | $31.6M | $13.3M | $87.6M | $80.1M | $69.0M |
| Cash From Investing | -$18.6M | -$22.6M | -$74.0M | -$48.2M | -$288.7M | -$71.5M |
| Cash From Financing | -$17.0M | $16.3M | $27.0M | -$6.8M | $207.1M | -$6.6M |
| Free Cash Flow | $19.0M | -$5.4M | -$38.5M | $46.4M | $41.8M | $9.9M |
| Dividends Paid | $19.4M | — | — | — | — | — |
Figures from Phibro Animal Health's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Phibro Animal Health financials page for every line item.
Phibro Animal Health Company Profile
| Ticker | PAHC |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Teaneck, New Jersey |
| Incorporated in | Delaware |
| Fiscal Year End | June 30 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001069899 |
Frequently Asked Questions
What was Phibro Animal Health's revenue in fiscal 2026?
Phibro Animal Health (PAHC) reported revenue of $1.52B for fiscal 2026.
What is Phibro Animal Health's annual revenue history?
Phibro Animal Health's annual revenue by fiscal year: 2021: $833.4M; 2022: $942.3M; 2023: $977.9M; 2024: $1.02B; 2025: $1.30B; 2026: $1.52B.
What was Phibro Animal Health's net income in fiscal 2026?
Phibro Animal Health reported net income of $99.7M for fiscal 2026.
What was Phibro Animal Health's earnings per share (EPS) in fiscal 2026?
Phibro Animal Health's diluted EPS was $2.43 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Phibro Animal Health generate in fiscal 2026?
Phibro Animal Health generated $9.9M of free cash flow in fiscal 2026.
What was Phibro Animal Health's revenue last quarter?
In its most recent reported quarter (2026 Q4), Phibro Animal Health reported revenue of $396.7M.
How much debt does Phibro Animal Health have?
Phibro Animal Health reported $732.8M of long-term debt, including the current portion, at the end of fiscal 2026.
How many shares of Phibro Animal Health are outstanding?
Phibro Animal Health reported a weighted average of 40.5 million basic shares outstanding in 2026 Q4.
What is Phibro Animal Health's market cap?
Based on its latest closing price, Phibro Animal Health (PAHC) has a market capitalization of about $1.51B.
When does Phibro Animal Health's fiscal year end?
Phibro Animal Health's fiscal year end, as registered with the SEC, is June 30.
Where is Phibro Animal Health headquartered?
Phibro Animal Health lists its business address in Teaneck, New Jersey in its SEC filings.